SCHEMBL1702572

SCHEMBL1702572

CCOC(=O)C(=O)c1c(S(C)(=O)=O)cc2cc(O[Si](C(C)C)(C(C)C)C(C)C)ccc2c1-c1ccc(Cl)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.35
CSF1R P07333 1/20 0.35
LMNA P02545 3/20 0.34
MAPT P10636 2/20 0.34
ALDH1A1 P00352 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MEN1 O00255 1/20 0.33
HPGD P15428 1/20 0.33
FPR1 P21462 1/20 0.33
TARBP2 Q15633 1/20 0.33
POLB P06746 2/20 0.33
CYP1A2 P05177 2/20 0.33
ATM Q13315 1/20 0.33
NR1H2 P55055 1/20 0.32
SIRT2 Q8IXJ6 1/20 0.32
SIRT1 Q96EB6 1/20 0.32
SIRT3 Q9NTG7 1/20 0.32
GABRA2 P47869 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1699614 0.88 LMNA (0.36) CSF1RLMNAMAPTALDH1A1TDP1
SCHEMBL1699441 0.73 PTGDR2 (0.37) CSF1RMAPTALDH1A1KMT2AMEN1
SCHEMBL1701370 0.71 CSF1R (0.41) CSF1RLMNAMAPTALDH1A1TDP1
SCHEMBL15165287 0.71 CSF1R (0.40) CSF1RMAPTALDH1A1TDP1HPGD
SCHEMBL1699598 0.69 CXCR1 (0.31) MAPTALDH1A1TDP1KMT2AKDM4E
SCHEMBL1699534 0.66 CSF1R (0.47) CSF1RALDH1A1TDP1HPGDCYP1A2
SCHEMBL1701364 0.65 CSF1R (0.41) CSF1RLMNAMAPTALDH1A1TDP1
SCHEMBL12630098 0.64 RXFP1 (0.57) LMNAALDH1A1KMT2AKDM4EMEN1
SCHEMBL1699564 0.63 HTT (0.42) CSF1RALDH1A1KMT2AMEN1HPGD
SCHEMBL10271593 0.63 CYP3A4 (0.38) LMNAMAPTALDH1A1TDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588450-A1 NAPHT- 2 -YLACETIC ACID DERIVATIVES TO TREAT AIDS Gilead Sciences, Inc. (US) 2013-05-08 EP disclosed
WO-2012003497-A1 NAPHT- 2 -YLACETIC ACID DERIVATIVES TO TREAT AIDS GILEAD SCIENCES, INC. (US) 2012-01-05 WO disclosed